Catalyst Wire Dossier Catalyst Wire Dossier

Cabergoline Tablets

cabergoline · Par Pharmaceutical, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cabergoline Tablets, covering 2008-04-04 to 2008-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions [Phase 1]

See pricing